MediciNova announces update on phase 2b trial

A board to discuss future MS therapies in early stage (Phase I or II) trials.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:
Contact MSUK

MediciNova announces update on phase 2b trial

Post by MSUK »

MediciNova has announced that the ongoing clinical trial of MN-166 (ibudilast) in patients with progressive multiple sclerosis (PMS) has finished the randomisation of 255 patients, exceeding the initial goal of 250 patients........ Read More - http://www.ms-uk.org/MN-166
MS-UK - http://www.ms-uk.org/
Top
Post Reply

Return to “Drug Pipeline”